Cargando…
Making Change Happen in Health
Integrating personalised medicine into Europe's healthcare systems will undoubtedly need to draw upon diverse talents via a multi-stakeholder approach taking expertise from academia, industry, healthcare organisations, government, policymakers and, of course, patient groups. It will also need a...
Autores principales: | Horgan, Denis, Smand, Carin, Negrouk, Anastassia, Lacombe, Denis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945910/ https://www.ncbi.nlm.nih.gov/pubmed/31988935 http://dx.doi.org/10.1159/000479547 |
Ejemplares similares
-
International clinical trials setting for rare cancers: organisational and regulatory constraints—the EORTC perspective
por: Shash, Emad, et al.
Publicado: (2013) -
Cross-Border Access to Clinical Trials in the EU: Exploratory Study on Needs and Reality
por: Lalova, Teodora, et al.
Publicado: (2020) -
Make Change Happen
por: Coyne, Ian
Publicado: (2014) -
International Rare Cancers Initiative (IRCI)
por: Keat, Nicola, et al.
Publicado: (2013) -
Current models, challenges and best practices for work conducted between European academic cooperative groups and industry
por: Stahel, Rolf A, et al.
Publicado: (2020)